Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
Work
Year: 2020
Type: article
Source: The Lancet Respiratory Medicine
Institutions University of Michigan–Ann Arbor, University of California, Los Angeles, Nippon Medical School, Délégation Paris 5, Université Paris Cité +6 more
Cites: 33
Cited by: 505
Related to: 10
FWCI: 56.79
Citation percentile (by year/subfield): 99.99
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: green
Funder F. Hoffmann-La Roche